Abbott Laboratories (ABT) Yield on Cost (YOC): 2.74%
The yield on cost (YOC) for Abbott Laboratories (ABT) is 2.74%.
ABT Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
2.74%
Yield on Cost for ABT
ABT now pays $2.44 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 10 years ago(2016-06-08) | $38.91 | 6.27% |
| 5 years ago(2021-06-16) | $110.06 | 2.22% |
| 3 years ago(2023-06-06) | $102.62 | 2.38% |
| 1 year ago(2025-06-10) | $134.13 | 1.82% |
| Buying today(at $89.17) | $89.17 | 2.74% |
If you buy today and the dividend keeps growing
Projection: starting from today's 2.74% yield, assuming the dividend keeps compounding at its historical 10.4% rate. Boards set dividends each year, so actual figures will differ.
Today
2.74%
In 3 years
3.59%
In 5 years
4.30%
In 10 years
6.75%
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for Abbott Laboratories (ABT).
Starting Yield
2.74%
Ending YOC
12.05%
Year 15 Dividend
$10.75
Cum. Dividends Recd.
$88.27
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $2.44 | — | 2.74% | $0.00 |
| Year 1 | $2.69 | +10.39% | 3.02% | $2.69 |
| Year 2 | $2.97 | +10.39% | 3.33% | $5.67 |
| Year 3 | $3.28 | +10.39% | 3.68% | $8.95 |
| Year 4 | $3.62 | +10.39% | 4.06% | $12.57 |
| Year 5 | $4.00 | +10.39% | 4.49% | $16.57 |
| Year 6 | $4.42 | +10.39% | 4.95% | $20.99 |
| Year 7 | $4.87 | +10.39% | 5.47% | $25.86 |
| Year 8 | $5.38 | +10.39% | 6.03% | $31.24 |
| Year 9 | $5.94 | +10.39% | 6.66% | $37.18 |
| Year 10 | $6.56 | +10.39% | 7.35% | $43.74 |
| Year 11 | $7.24 | +10.39% | 8.12% | $50.98 |
| Year 12 | $7.99 | +10.39% | 8.96% | $58.97 |
| Year 13 | $8.82 | +10.39% | 9.89% | $67.79 |
| Year 14 | $9.74 | +10.39% | 10.92% | $77.52 |
| Year 15 | $10.75 | +10.39% | 12.05% | $88.27 |
Abbott Laboratories Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Abbott Laboratories Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Abbott Laboratories (ABT)?
- The yield on cost (YOC) for ABT stock is 2.74%.
About Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Robert Ford